The autonomic nervous system may play an important role in tissue autoregulation as the neurohumoral transmission process has been shown to constitute the final common pathway by which the effects of many physiological and pharmacological substances are mediated. The effects of the administration of a sympathomimetic amine cannot be accurately predicted in a subject. Choice of which sympathomimetic amine to use should be determined on the basis of data obtained in relevant clinical circumstances, but the dose should always be titrated against the effect in each individual.
It is interesting that adrenaline, “the original autonomic drug” with its “venerable history”,56 is still a first line drug in many of the situations for which it was being prescribed in 1907. It is the drug of first choice in anaphylactic reactions and for severe allergic bronchospasm, and is widely used as a vasoconstrictor in surgery and with local anaesthetic agents. Adrenaline in “physiological” doses is a satisfactory and cheap alternative to other available drugs for use in septic shock and in emergence from cardiopulmonary bypass.
Euler von US.Adrenaline and noradrenaline: distribution and action. Pharm Rev1954; 6: 15–22.
8.
AhlquistR.P.A study of the adrenotropic receptors. Am J Physiol1948; 153: 586–599.
9.
CallinghamB.A., BarrandM.A.Catecholamines in blood. J Pharm Pharmacol1976; 28: 356–360.
10.
StjarneL.Basic mechanisms and local feedback control of secretion of adrenergic and cholinergic neurotransmitters. In: The Handbook of Psychopharmacology Vol 6. Plenum Publishing Corporation, New York1975.
11.
WestfallT.C.Local regulation of adrenergic neurotransmission. Physiol Rev1977; 57, 4: 659–728.
12.
Euler von US.Noradrenaline, American Lecture Series No 261.Charles C. Thomas, Springfield, Illinois, USA1956.
13.
Cotten M deV., UdenfriendS., SpectorS.Regulation of catecholamine metabolism in the sympathetic nervous system. The American Society for Pharmacology and Experimental Therapeutics, Williams & Wilkins Company, Baltimore1972.
14.
CooperJ.R., BlomF.E., RothR.H. In: The Biochemical Basis of Neuropharmacology 2nd ed. Oxford University Press1974.
15.
GoodmanL.S., GilmanA.G.The pharmacological basis of therapeutics.Macmillan Publishing Co. Inc., New York1975.
16.
lversonL.L.Adrenal gland. In: Handbook of Physiology, Section 7, Endocrinology, VI.Am Soc Physiol, Williams and Wilkins, Baltimore1976.
17.
GoldbergL.I.Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol Rev1972; 24: 1–29.
18.
GinsburgJ., CobboldA.F.Adrenergic mechanisms in man: Effects of adrenaline, noradrenaline and isopropylnoradrenaline in man. CIBA Foundation Symp on Adrenergic Mechanisms, ed Vane JR, Walstenholme GEW, O'Connor KM. Little, Brown, Boston1960; 0: 173–189.
19.
GoldenbergM., PinesK.L., BaldwinEdeF, GreeneD.G., RohC.E.The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension. Am J Med1948; 5: 792–806.
20.
GoldbergL.I.The pharmacological basis of the clinical use of dopamine. Proc Roy Soc Med1977; Suppl 2: 17–15.
21.
BarcroftH., KonzettH.On the actions of noradrenaline, adrenaline and isopropyl noradrenaline on the arterial blood pressure, heart rate and muscle blood flow in man. J Physiol1949; 110: 194–204.
22.
AkhtarN., MikulicE., CohnJ.N., ChaudhryM.Haemodynamic effect of dobutamine in patients with severe heart failure. Am J Cardiol1975; 36: 202–205.
23.
MeyerS.L., CurryG.C., DonskyM.S., TwiegD.B., ParkeyR.W., WillersonJ.T.Influence of dobutamine on haemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol1976; 38: 103–108.
24.
TinkerJ.H., TarhanS., WhiteR.D., PluthJ.R., BarnhorstD.A.Dobutamine for inotropic support during emergence from cardiopulmonary bypass. Anesthesiology1976; 44: 281–286.
25.
LoebH.S., BredakisJ., GunnarR.M.Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation1977; 55: 375–381.
26.
VendsaluA.Studies on adrenaline and noradrenaline in human plasma. Acta Physiol Scand1960; 49: Suppl 173.
27.
FerreiraS.H., VaneJ.R.Half lives of peptides and amines in the circulation. Nature1967; 215: 1237–1240.
28.
CallinghamB.A.Adrenal gland. In: The Handbook of Physiology, Section 7, Endocrinology, VI.Am Soc Physiol, Williams and Wilkins, Baltimore1976.
29.
AronowW.S., HardingP.R., DeQuattroV., IsbellM.Diurnal variation of plasma catecholamines and systolic time intervals. Chest1973; 63: 722–726.
30.
TurtonM.B., DeeganT.Circadian variations of plasma catecholamine, Cortisol and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta1974; 55: 389–397.
31.
ZieglerM.G., LakeC.R., KopinI.J.Plasma noradrenaline increases with age. Nature1976; 261: 333–335.
32.
EngelmanK., PortnoyP.A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Circ Res1970; 26: 53–57.
33.
ChristensenN.J.Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin Sci Mol Med1973; 45: 163–171.
34.
CryerP.E., SantiagoJ.V., ShahS.Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endoc Metabol1974; 39(6): 1025–1029.
35.
ChristensenN.J., BrandsborgO.The relationship between plasma catecholamine concentration and pulse rate during exercise and standing. Europ J Clin Invest1973; 3: 299–306.
36.
ClancyL.J., CritchleyJ.A., LeitchA.G., KirbyB.J., UngarA., FlenleyD.C.Arterial catecholamines in hypoxic exercise in man. Clin Sci Mol Med1975; 49: 503–506.
37.
MoermanE.J., BogaertM.G., DeSchaepdryverA.F.Estimation of plasma catecholamines in man. Clin Chim Acta1976; 72: 89–96.
38.
ChristensenN.J., VidebaekJ.Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest1974; 54: 278–286.
39.
StrangeR.C., VetterN., RoweM.J., OliverM.F.Plasma cyclic AMP and total catecholamines during acute myocardial infarction in man. Europ J Clin Invest1974; 4: 115–119.
40.
ChristensenN.J., AlbertiK.C., BrandsborgO.Plasma catecholamines and blood substrate concentrations. Studies in insulin induced hypoglycaemia and after adrenaline infusions. Europ J Clin Invest1975; 5: 415–423.
41.
TanC.K., GlissonS.N., El-EtrA.A., RamakrishnaiahK.B.Levels of circulating norepinephrine and epinephrine before, during, and after cardiopulmonary bypass in man. J Thor Cardiovasc Surg1976; 71(6): 928–931.
NikkiP., TakkiS., TammistoT., JaattelaA.Effect of operative stress on plasma catecholamine levels. Ann Clin Res1972; 4: 146–151.
44.
MatsukiA., KotharyS.P., ZsigmondE.K.Effects of gallamine on plasma Cortisol and catecholamine levels in man. Can Anaesth Soc J1973; 20(4): 539–545.
45.
TammistoT., TakkiS., NikkiP., JaattelaA.Effect of operative stress on plasma catecholamine levels during neuroleptanalgesia. Anaesthetist1973; 22: 158–161.
46.
HineI.P., WoodW.G., Mainwaring-BurtonR.W., ButlerM.J., IrvingM.H.The adrenergic response to surgery involving cardiopulmonary bypass, as measured by plasma and urinary catecholamine concentrations. Br J Anaesth1976; 48: 355–363.
47.
HanquetM., Cession-FossionA., LeComteJ.Changes in catecholamine levels during shock in man. Can Anaesth Soc J1970: 208–212.
48.
DeQuattroV., ChanS.Raised plasma-catecholamines in some patients with primary hypertension. Lancet1972; April 15: 806–809.
49.
LouisW.J., DoyleA.E., AnevekarS.Plasma norephinephrine levels in essential hypertension. N Engl J Med1973; 288(12): 599–601.
50.
ImaiK., WangM.T., YoshiueS., TamuraZ.Determination of catecholamines in the plasma of patients with essential hypertension and of normal persons. Clin Chim Acta1973; 43: 145–149.
51.
PedersenE.B., ChristensenN.J.Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand1975; 198: 373–377.
52.
MangerW.M., FrohlichE.D., GiffordR.W., DustanH.P.Norepinephrine infusion in normal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate, and plasma catecholamine concentrations, J Clin Pharm1976; 16(2): 129–141.
53.
GeffenL.B., RushR.A., LouisW.J., DoyleA.E.Plasma catecholamine and dopamine beta-hydroxylase amounts in phaechromocytoma. Clin Sci1973; 44: 421–424.
54.
CohenG., HollandB., ShaJ., GoldenbergM.Plasma concentrations of epinephrine and norepinephrine during intravenous infusions in man. J Clin Invest1959; 38: 1935–1941.
55.
ZuspanF.P., NelsonG.H., AhlquistR.P.Epinephrine infusions in normal and toxaemic pregnancies. Am J Obstet Gynaecol1965; 9(8): 1102–1106.
56.
HaggendalJ., SvedmyrN.The effect of triiodothyronine treatment on the catecholamine content of the blood during infusion of adrenaline in man. Acta Physiol Scand1966; 66: 103–105.
57.
SapiraJ.D., BronK.Human epinephrine secretion. Direct measurement of the secretion of epinephrine from the human adrenal medulla. J Clin Endoc Metabol1971; 33: 436–447.
58.
AhlqistR.P.Circulation. Handbook of Physiology, Section 2, Am Soc Physiol, III.Williams and Wilkins, Baltimore; 1965.
59.
BearnA.G., BillingB., SherlockS.The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol1951; 115: 430–441.
60.
KingB.D., SokoloffL., WechslerR.L.The effects of 1-epinephrine and 1-norepinephrine upon cerebral circulation and metabolism in man. J Clin Invest1951; 31: 273–279.
61.
SmytheC.M., NickelJ.F., BradleyS.E.The effect of epinephrine (USP), 1-epinephrine, and 1-norepinephrine on glomerular filtration rate, renal plasma flow and the urinary excretion of sodium, potassium and water in normal man. J Clin Invest1952; 31: 499–506.
62.
GombosE.A., HuletW.H., BoppP., GoldringW., BaldwinD.S., ChasisH.Reactivity of renal and systemic circulations to vasconstrictor agents in normotensive and hypertensive subjects. J Clin Invest1962; 41(2): 203–217.
63.
SchoeppeW.Effects of dopamine on kidney function. Proc Roy Soc Med1977; 70, Suppl 2: 36–42.
SvedmyrN., SimonssonB.G.Drugs in the treatment of asthma. Pharmac Therap B1978; 3: 397–440.
66.
RosenbergJ.C., LilleheiR.C., LongerbeamJ., ZimmermannB.Studies on hemorrhagic and endotoxin shock in relation to vasomotor changes and endogenous circulating epinephrine, norepinephrine and serotonin. Ann Surg1961; 154(4): 611–628.
67.
LilleheiR.C., LongerbeamJ.K., BlockJ.H., ManaxW.G.The nature of irreversible shock: experimental and clinical observations. Ann Surg; 160, 682.
68.
BlockJ.H., DietzmanR.H., PierceC.H., LilleheiR.C.Theories of the production of shock. Br J Anaesth1966; 38: 234–250.
69.
OgburnP.The role of vasoactive agents in shock therapy. Vet Clin N Am1976; 6(2): 287–295.
70.
AlhoA., JaattelaA., LahdensuuM.Catecholamines in shock. Ann Clin Res1977; 9: 157–163.
71.
LoebH.S., WinslowE.B.J., RahimtoolaS.H., RosenK.M., GunnarR.M.Acute hemodynamic effects of dopamine in patients with shock. Circ1971; XLIV: 163–173.
72.
SiegelJ.H., GoldwynR.M., FriedmanH.P.Pattern and process in the evolution of human septic shock. Surg1971; 70: 232–245.
73.
WinslowE.J., LoebH.S., RahimtoolaS.H., KamathS., GunnarR.M.Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med1973; 54: 421–432.
74.
RosenblumR.Appraisal and reappraisal of cardiac therapy: physiologic basis for the therapeutic use of catecholamines. Am Heart J1974; 87: 527–530.
75.
GoldbergL.I., Drug therapy. Dopamine — clinical uses of an endogenous catecholamine. N Engl J Med1974; 291: 707–710.
76.
GreeverC.H., WattsD.T.Epinephrine levels in the peripheral blood during irreversible hemorrhagic shock in dogs. Circ Res1959; 7: 192–195.
77.
RobinsonR.L., WattsD.T.Inhibition of adrenal secretion of epinephrine during infusion of catecholamines. Am J Physiol1962; 203: 713–716.
78.
DarbyT.D., WattsD.T.Acidosis and blood epinephrine levels in hemorrhagic hypotension. Am J Physiol1964; 206: 1281–1284.
79.
SpinkW.W., ReddinJ., ZakS.J., PetersonM., StarzeckiB., SeljeskogE.Correlation of plasma catecholamine levels with hemodynamic changes in canine endotoxin shock. J Clin Invest1966; 45: 78–85.
80.
BraunwaldE.Mechanics and energetics of the normal and failing heart. Trans Assoc Am Physicians1971; 84: 63–94.
81.
KonesR.J.The catecholamines: reappraisal of their use for acute myocardial infarction and the low cardiac output syndrome. Crit Care Med1973; 1: 203–220.
82.
GoodyerA.V.N.Left ventricular function and tissue hypoxia in irreversible hemorrhagic and endotoxin shock. Am J Physiol1967; 212: 444–450.
83.
SiegelJ.H., GreenspanM., del GuercioL.R.M.Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg1967; 165: 504–517.
RobertsJ.G.Beta-adrenergic blockade and anaesthesia with reference to interactions with anaesthetic drugs and techniques. Anaesth Intens Care1980; 8: 318–335.
99.
InnesI.R., NickersonM.Norepineprine, epinephrine, and the sympathomimetic amines. In: The Pharmacological Basis of Therapeutics.GoodmanS., OilmanA.Macmillan Publishing Co Inc, New York, 1975.
100.
FisherM.M.cD.. Intradermal testing in the diagnosis of acute anaphylaxis during anaesthesia — results of five years experience. Anaesth Intens Care1979; 7: 58–61.
101.
McEwanL.M.Adrenaline in the treatment of anaphylaxis. Br Med1975; November 29: 519.
102.
FranklandA.W., Adel-MaguidR.Adrenaline in the treatment of anaphylaxis. Br Med J1975; October 18: 162.
103.
ForresterJ.S., DiamondG., McHughT.J., SwanH.J.C.Filling pressures in the right and left sides of the heart in acute myocardial infarction. N Engl J Med1971; 285: 190–193.
104.
KrauszM.M., PerelA., EimerlD., CotevS.Cardiopulmonary effects of volume loading in patients in septic shock. Ann Surg1977; 185: 429–434.
105.
RalstonD.H., ShniderS.M., deLorimerA.A.Effects of equipotent ephedrine, metaraminol, mephentermine, and methoxamine on uterine blood flow in the pregnant ewe. Anaesthesiology1974; 4: 354–370.
106.
GilbertR.P.Endotoxin shock in the primate. Proc Soc Exp Biol Med1962; 111: 328–331.
ThompsonW.L.Dopamine and other vaso–active agents in shock. Scot Med J1979; 24: 89–92.
109.
CrexellsC., ChatterjeeK., ForresterJ.S., DikshitK., SwanH.J.C.Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med1973; 289: 1263–1266.
110.
KonesR.J.Cardiogenic shock. Therapeutic implications of altered myocardial energy balance. Angiology1974; 25: 317–333.
111.
ForresterJ.S., DiamondG., ChatterjeeK., SwanH.J.C.Medical therapy of acute myocardial infarction by application of haemodynamic subsets. N Eng J Med1976; 295: 1356–1362.
112.
HaiderB., KhanM.I., BurkeW.M., ReganT.J.Ischaemic heart failure: sustained inotropic response to small doses of 1-epinephrine without toxicity. Am J Cardiol1975; 35: 504–513.
113.
LeschM.Inotropic agents and infarct size. Theoretical and practical considerations. Am J Cardiol1976; 37: 508–513.
114.
CrexellsC., BourassaM.G., BironP.Effects of dopamine on myocardial metabolism in patients with ischaemic heart disease. Cardiovasc Res1973; 7: 438–445.
115.
HolzerJ., KarlinerJ.S., O'RourkeR.A., PittW., RossJ.Effectiveness of dopamine in patients with cardiogenic shock. Am J Cardiol1973; 32: 79–84.
116.
KarlinerJ.S.Dopamine for cardiogenic shock. JAMA1973; 226: 1217–1218.
117.
CallinanV.I., HarrisonG.A.The use of large doses of adrenaline and other vasopressors in the low cardiac output syndrome after cardiac surgery — a report of four cases. Anaesth Intens Care1974; 2: 58–68.
118.
GattikerR., SchmidE.Haemodynamic effects of dopamine, epinephrine and orciprenaline in patients early after cardiac surgery. Intens Care Med1978; 4: 55–61.
119.
RosenblumR., FriedenJ.Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery. Am Heart J1972; 83: 743–748.
120.
HollowayE.L., StinsonE.B., DerbyG.C., HarrisonD.C.Action of drugs in patients early after cardiac surgery. Am J Cardiol1975; 35: 656–659.
121.
SteenP.A., TinkerJ.H., PluthJ.R., BarnhorstD.A., TarhanS.Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man: objective monitoring. Abstracts Am Soc Anesthesiologists Annual Meeting, New Orleans, Louisiana 1977; 515–516.
122.
SakamotoT., YamadaT.Hemodynamic effects of dobutamine in patients following open heart surgery. Circ1977; 55: 525–533.
123.
BeaumontG.D.The effects of topical cocaine and adrenaline anaesthesia of the nose combined with general anaesthesia. J Oto-Laryngol Soc Aust1974; 3: 691–696.
124.
SchenkN.L.Local anaesthesia in otolaryngology. A re-evaluation. Ann Otol1975; 84: 65–72.
125.
FeehanH.F., Mancusi-UngaroA.Use of cocaine as a topical anaesthetic in nasal surgery: survey report. Plast Reconstr Surg1976; 57: 62–65.
126.
DelilkanA.E., GnanapragasamA.Topical cocaine/adrenaline combination in intranasal surgery — Is it really necessary?Anaesth Intens Care1978; 6: 328–332.
127.
JordanW.S., GravesC.L., ElwynR.A.New therapy for post intubation laryngeal oedema and tracheitis in children. JAMA1970; 212: 585–588.
128.
AdairJ.C., RingW.H., JordanW.S., ElwynR.A.Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis. Anaesth Analg Curr Res1971; 50: 649–655.
129.
MatherL.E., TuckerG.T., MurphyT.M., Stanton-HicksM.D.'A, BonicaJ.J.The effects of adrenaline to etidocaine and lignocaine in extradural anaesthesia. II: Pharmacokinetics. Br J Anaesth1976; 48: 989–992.
130.
MurphyT.M., MatherL.E., Stanton-HicksM.D.'A, BonicaJ.J., TuckerG.T.The effects of adding adrenaline to etidocaine and lignocaine in extradural anaesthesia. I: Block characteristics and cardiovascular effects. Br J Anaesth1976; 48: 893–897.
131.
LilienthalB., ReynoldsA.K., CoffinR.D., ArcherF.E.Comparative circulatory effects of adrenaline and noradrenaline during intra-osseous dental anaesthesia, Int J Clin Pharmacol1975; 11: 336–339.
132.
FraunfelderF.T., ScafidiA.F.Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthal1978; 85: 447–453.
133.
CaritisS.N., EdestoneD.I., Meuller-HeubachE.Pharmacological inhibition of preterm labour. Am J Obstet Gynecol1979; 133: 557–578.
134.
LandsA.M., ArnoldA., McAuliffJ.P., LudvenaF.P., BrownT.G.Differentiation of receptor systems activated by sympathomimetic amines. Nature1967; 214: 597–598.
135.
WattsJMcK, McDonaldP.J., MarshallU.R., O'BrienP.L., eds. Infection in Surgery.Edinburgh: Churchill Livingstone1980; Chapter 21. In press.
